Vimarsana
Biggest News Aggregation in the World

Page 4 - Scienta Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scienta Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scienta Communications Today - Breaking & Trending Today

Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series - Vimarsana News

Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series

Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series - read this article along with other careers information, tips and advice on BioSpace

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly - Vimarsana News

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly

SAN DIEGO, Oct. 13, 2022 -- Crinetics Pharmaceuticals, Inc. today announced the completion of enrollment in the Phase 3 PATHFNDR-1 study. PATHFNDR-1 is one of two ongoing, placebo-controlled Phase... | October 13, 2022

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as - Vimarsana News

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as

SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the appointment of Dana Pizzuti, M.D., as...

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - Vimarsana News

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace

Cognition Therapeutics Announces Participation in September Investment Conferences - Vimarsana News

Cognition Therapeutics Announces Participation in September Investment Conferences

06.09.2022 - PURCHASE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) - Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule ...